Also, there were no cases of symptomatic Covid-19 among vaccine recipients, Moderna said, suggesting 100% vaccine efficacy in adolescents, though overall very few among the 3,700 children in the study got sick. The agency took about a month to clear Pfizer’s request for use of its Covid-19 vaccine in adolescents. In December, the Covid-19 vaccine from Pfizer and its partner BioNTech SE was cleared for 16- and 17-year-olds, along with adults. Earlier this month, the FDA authorized the Pfizer shot for use in children aged 12 to 15 years. “We are encouraged that mRNA-1273 was highly effective at preventing Covid-19 in adolescents," Moderna Chief Executive Stéphane Bancel said, referring to the vaccine’s code name.

Source: Mint May 25, 2021 16:41 UTC